"Courtesy" Letter Process Under Review At FDA

FDA plans to revisit its use of "courtesy" letters to respond to inappropriate dietary supplement claims, Center for Food Safety & Applied Nutrition's Robert Moore, PhD, said at a joint CRN/CHPA briefing in Washington, D.C. Feb. 16.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet